Open Evidence AI Review: Features, Accuracy, and Best Alternatives

Over 757,000 verified US physicians use OpenEvidence, making it the most adopted clinical AI tool in the country. More than 40% of US doctors log in daily across 10,000 hospitals and medical centers, and the platform processed over 20 million clinical consultations in a single month as of January 2026. But a Sermo physician survey found 44% of doctors cite accuracy and misinformation as their primary concern with clinical AI. That tension between widespread adoption and persistent distrust tells you where medical AI sits right now.

OpenEvidence is an AI-powered medical research assistant that answers clinical questions using peer-reviewed literature. You type a question, and it searches journals like NEJM, JAMA (including all eleven specialty journals), The Lancet, and over 300 other publications, plus FDA and CDC sources. It returns synthesized answers with inline citations so you can trace every claim back to the original paper.

The platform runs through the Mayo Clinic Platform Accelerate program and was founded in 2022 by Daniel Nadler and Zachary Ziegler. Unlike general-purpose chatbots, OpenEvidence restricts its source material to peer-reviewed publications and clinical guidelines. That constraint reduces hallucination risk compared to models trained on the open internet. But it also means the tool can only answer questions where published evidence exists. Novel clinical scenarios, rare diseases with thin literature, or questions requiring synthesis across unpublished data fall outside its reach.

Access requires physician verification through an NPI number or institutional credentials. Medical students can sign up with verified enrollment. The tool is available as a native iOS and Android app, plus a web interface.

OpenEvidence processes requests through two modes. Quick Consult handles direct clinical questions, returning answers in seconds with journal citations. Deep Consult runs longer, synthesizing evidence from multiple sources for complex or ambiguous questions. Both modes provide a Reasoning Trace that shows how the AI weighed conflicting studies. That transparency is rare among clinical AI tools and helps physicians evaluate synthesis quality rather than accepting answers at face value.

Clinical Tools

The platform includes over 50 clinical calculators for common assessments and a clinical trial matching feature that connects patient profiles to active studies. These additions push OpenEvidence beyond pure literature search into point-of-care support, though the calculator library is smaller than dedicated tools like MDCalc.

Voice Mode and Ambient Features

A hands-free voice AI feature launched in 2026, letting clinicians ask questions without touching a screen. This matters in surgical suites, exam rooms, and any setting where sterile fields make typing impractical. The voice interface runs the same Quick Consult and Deep Consult pipeline as the text version.

The Visits feature transcribes patient encounters and generates clinical summaries. In March 2026, the platform added AI-powered medical coding that suggests CPT codes and E/M level recommendations from visit transcripts. These features position OpenEvidence to compete with ambient documentation tools like Abridge and Nabla.

Publisher Partnerships

OpenEvidence has direct licensing agreements with NEJM, all eleven JAMA specialty journals, NCCN, ACC, AAFP, ACEP, ADA, AAOS, and AAOHNS, among others. FDA and CDC content feeds add regulatory and public health context. That publisher network gives it deeper journal access than most competitors, and it is a real moat.

EHR Integration

The platform announced EHR integration with Sutter Health through Epic in February 2026, and Cedars-Sinai expanded its institutional deployment. Most physicians still use OpenEvidence as a standalone app. Full chart-aware clinical support, where the AI reads patient records and proactively surfaces relevant evidence, is not available yet.

What It Does Not Do

OpenEvidence does not generate differential diagnoses. It will not calculate drug dosing or check interactions. It lacks drug database integration entirely. If you need those capabilities, tools like UpToDate, DynaMed, or Glass Health cover that ground.

OpenEvidence scores well on standardized medical exams, reporting 100% on USMLE-type questions. Clinical AI Report rated the platform 81 out of 100 for clinical accuracy and 90 out of 100 for evidence and citations. On the App Store, it holds a 4.9 out of 5 rating from nearly 7,000 reviews.

Those numbers look strong until you test against harder cases. A December 2025 preprint by Jagarapu et al. evaluated OpenEvidence on complex subspecialty scenarios and found accuracy of just 41% for Deep Consult and 34% for Quick Consult. The gap between exam performance and real-world clinical complexity is wide.

A peer-reviewed study published in PMC evaluated OpenEvidence across five common chronic conditions: hyperlipidemia, hypertension, depression, type 2 diabetes, and obesity. Four independent physicians rated the responses on a 0-to-4 scale. Results were strong for clarity (3.55), relevance (3.75), and evidence support (3.35). But impact on clinical decision-making scored just 1.95 out of 4. The researchers concluded that OpenEvidence excels at reinforcing existing physician decisions rather than changing them.

That reinforcement pattern matters. If you are a primary care physician confirming a treatment approach or finding the latest guideline for a common condition, OpenEvidence performs well. For rare presentations, conflicting evidence, or cases requiring clinical judgment beyond published literature, the tool's value drops noticeably.

The Sermo survey adds context: 37% of physicians said peer-reviewed validation is the single factor that would most encourage them to adopt clinical AI. Only 20% are fully supportive of AI in clinical decision-making, while 54% describe themselves as cautiously open. That caution is rational given the accuracy gap between routine and complex cases.

Organize Your Clinical Research in One Searchable Workspace

Upload papers, clinical notes, and AI-generated summaries to a workspace that indexes everything for semantic search. Starts with a 14-day free trial.

Start 14-Day Trial

OpenEvidence is free for verified US healthcare professionals. The company funds the platform through pharmaceutical advertising and sponsored research content, similar to how medical journals operate. That ad-supported model helped drive massive adoption, but it raises questions about content neutrality when sponsored results appear alongside clinical evidence.

The company closed a $250 million Series D in January 2026 at a $12 billion valuation, led by Thrive Capital and DST. Total funding exceeds $735 million, and annual revenue reached $100 million. The valuation doubled from $6 billion to $12 billion in just three months between the Series C and Series D rounds. CEO Daniel Nadler has publicly indicated the company is exploring changes to its revenue approach, which suggests the free model may not last indefinitely.

Geographic Availability

OpenEvidence officially withdrew from both the European Union and the United Kingdom in April 2026. The company cited regulatory uncertainty around the EU Artificial Intelligence Act, which would classify the platform as a high-risk AI system requiring constant audits, algorithmic transparency, and bias evaluations. The platform also requires NPI verification, a US-specific credential, which limits access for international clinicians in Canada, Australia, and Asia.

If you practice outside the US, Dr.Oracle covers US, UK, and European guidelines. iatroX serves UK clinicians with NICE, CKS, and SIGN guideline integration. Both are free.

OpenEvidence covers a specific slice of clinical AI: literature search with AI synthesis. Depending on your workflow, one of these alternatives may be a better fit.

1. UpToDate UpToDate remains the benchmark for clinical reference. It covers over 12,000 topics maintained by 7,400 physician authors with continuous updates. Unlike OpenEvidence's AI synthesis approach, UpToDate delivers expert-written summaries graded by evidence quality.

Best for: Physicians who want human-curated evidence over AI-generated synthesis.

Pricing: Institutional subscription required, typically $500 or more per year for individual access.

Limitation: No AI chat interface. Search is keyword-based, not conversational.

2. Glass Health

Glass Health combines ambient scribing with clinical decision support. It generates differential diagnoses from patient presentations, filling a key gap in OpenEvidence. The platform connects to EHR systems and offers chart summarization alongside clinical Q&A.

Best for: Clinicians who want documentation and clinical support in one tool.

Pricing: Free (Lite), $20/month (Starter), $90/month (Pro), $200/month (Max).

Limitation: EHR integration requires institutional setup and pilot testing.

3. DynaMed

DynaMed, owned by EBSCO, covers 3,400 clinical topics with daily updates. It won Best in KLAS for Clinical Decision Support four times between 2021 and 2025. DynaMed includes drug information and interaction checking that OpenEvidence lacks entirely.

Best for: Evidence-based reference with drug database integration.

Pricing: Institutional or individual subscription through EBSCO.

Limitation: Interface feels dated compared to AI-native tools.

4. Doximity DoxGPT

Doximity is the largest physician network in the US, with over 3 million registered members covering 85% of US physicians. DoxGPT, expanded through the Pathway Medical acquisition, provides evidence-based clinical answers, 3,200 drug monographs, and PeerCheck physician review alongside networking and telehealth.

Best for: Physicians who want clinical AI integrated with professional networking.

Pricing: Free base access. Premium features require a Pro subscription.

Limitation: Clinical AI features are newer and less tested than dedicated platforms.

5. AMBOSS

AMBOSS bridges medical education and clinical practice. Its AI Mode provides clinical answers alongside learning resources, making it valuable in teaching hospitals and residency programs. The platform covers board prep and point-of-care support in a single subscription.

Best for: Residents, medical students, and teaching hospitals.

Pricing: 5-day free trial. Subscription pricing on their website.

Limitation: Stronger for learning than production clinical use.

6. Vera Health

Vera Health searches over 60 million peer-reviewed papers and includes 800 clinical calculators and drug dosing tools, addressing two of OpenEvidence's biggest gaps. The Y Combinator-backed platform is free for clinicians and was recently rated the top OpenEvidence alternative by Clinical AI Report.

Best for: Clinicians who need drug dosing and calculators alongside AI literature search.

Pricing: Free for clinicians.

Limitation: Smaller publisher partnership network than OpenEvidence.

Each clinical AI tool generates output: saved queries, exported summaries, downloaded papers, annotated guidelines. As your workflow spans multiple platforms, organizing that research output becomes its own problem.

Local folders work for individual use. Google Drive and Dropbox handle basic file storage and sharing. For teams that need to search across accumulated research files by meaning rather than filename, workspace platforms with built-in AI indexing offer more.

Fast.io provides workspaces where uploaded documents are automatically indexed for semantic search. Enable Intelligence Mode on a workspace, and you can ask questions across your entire research library with cited answers. Plans include workspace storage and monthly AI credits, and every org starts with a 14-day free trial. Researchers working with AI agents can also access files through the Fast.io MCP server, which supports automated research workflows where agents read, write, and organize files in shared workspaces.

Fast.io will not replace OpenEvidence or any clinical AI tool for answering medical questions. It fills a different gap: organizing the files and notes those tools produce into a searchable, shareable workspace that your whole research team can query.